Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Sanara MedTech Inc. Director's Dealing 2025

Jan 21, 2025

33339_dirs_2025-01-21_d3bb28c1-a26c-490a-b6b0-f19fb869daed.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2025-01-15

Reporting Person: Taylor Elizabeth B (Chief Financial Officer)

More from Sanara MedTech Inc.

Interim / Quarterly Report 2026
May 12
Regulatory Filings 2026
May 11
Proxy Solicitation & Information Statement 2026
Apr 17
Annual Report 2026
Apr 17
Proxy Solicitation & Information Statement 2026
Apr 17
Proxy Solicitation & Information Statement 2026
Apr 17
Major Shareholding Notification 2026
Apr 14
Annual Report 2026
Mar 24
Regulatory Filings 2026
Mar 24
Director's Dealing 2026
Mar 23
View all filings →